News /

Liberum's AstraZeneca research highlighted in Telegraph's 2014 outlook

28 December 2013 | Mentions of Liberum

Equities research on AstraZeneca published by Liberum pharmaceuticals analyst Naresh Chouhan (below) is singled out by the editor of the Telegraph's Questor column in the newspaper's outlook for 2014 published on December 28, 2013. 

Ten of its journalists each picked an idea that would benefit from the improving business climate. Naresh's work, originally published on November 15, 2013, was the sole piece of research identified in the article by Questor Editor John Ficenic.

Other companies named in the piece that are also covered by Liberum are: Imagination Technologies. Research was published December 12, 2013 by technology analyst Eoin LambeDrax. Utilities analyst Peter Atherton published on the company November 18, 2013; Barrat Developments. Housebuilders analyst Charlie Campbell issued sector research that included the company on October 29, 2013; FirstGroup. Transport analyst Gerald Khoo initiated coverage of the UK transportation sector on December 9, 2013.

(This communication is for information purposes only and should not be regarded as an offer or solicitation to buy or sell any security. Please visit our Conflicts of Interest policy for further information.)